Pharmalot, Pharmalittle: Valeant under criminal investigation for defrauding insurers

Good morning, everyone, and how are you today? We are doing reasonably well, thank you, especially as a busy week. But this is to be expected in a busy world, right? So please join us to cope by drinking another cup of stimulation. Remember, no prescription is required. Meanwhile, here are some facts to help you along. We hope you have a sensational day and makes us drop a line when something fascinating …

Federal prosecutors are conducting a criminal investigation to determine whether Valeant Pharmaceuticals defrauded insurers to hide Philidor its relationship with Rx Services , a drug that was used to boost prescription medications the Wall Street Journal reports. The question is whether insurers Philidor thought was rather neutral Valeant actively promoting drugs. Valeant had acquired an option to purchase Philidor, but did not disclose that for many months and only recognized the relationship after report .

In his quest to win customers in India, administrators of Abbott Laboratories instructed employees to pursue sales at almost any cost The New York Times reports. But this would have been done in violation of Indian law, professional medical standards and ethics guidelines own company. Last month, Ashish Awasthi, 35, was found dead on a railway track and a note recovered from the company and blamed the pressure to hit sales targets his death.

The article continues after the announcement

The Department of Veterans Affairs US is expanding the coverage of new antiviral treatments to all veterans with hepatitis C , regardless stage of their disease and if these infections are acquired during military service, according to Journal of the American medical Association. The agency is initiating therapy 1,100 patients a week – twice a year ago -. And hopes to increase to 2,000 patients a week later this year

The Food and Drug United States agreed to review a Marathon treatment Pharmaceutical Products for Duchenne Muscular Dystrophy , Chicago Tribune tells us. Known as the deflazacort, the drug is already available outside the US, where it has been approved for other uses. But because the steroid does not have FDA approval, the drug is not widely available here.

Tax incentives for drug manufacturers : Allergan will use more than $ 58 million in incentives from a state agency in New Jersey to consolidate its current operations and develop a new US headquarters in an installation in Madison before the end of 2017 NJBiz writes. Moreover, Pfizer has won the first part of its application for a tax on a planned expansion of its manufacturing plant in Portage, Michigan. $ 145 million, according to MLive .

AstraZeneca has invested another $ 140 million in Moderna Therapeutics, raising its stake to 9 percent in the company, which is developing based on a molecule known as messenger RNA drugs Reuters says .

volunteers for clinical trials in India complained to the National Human Rights Commission that some clinical research organizations violate certain regulations and participants exploited PharmaBiz tells us.

A former partner of the law firm Hunton & Williams and investment adviser were criminally charged with participating in a scheme of insider trading ahead of an agreement Pfizer The Wall Street Journal writes.

After two rejections, the FDA finally approved Garza long-acting injectable therapeutics for the prevention of nausea induced by chemotherapy Reuters reports.

PharmaTech recalled drugs made at a plant in Florida that an outbreak of B. cepacia was linked last month, according to Inpharma technologist .

The National Health Service of England launched a public consultation 45 days on a policy set in motion proposed clinical treatment of HIV PrEP PharmaTimes writes.

Therapeutic Goods Administration of Australia approved changes to the drug labels of prescription and over the counter to align with international practices, Regulatory approach informs us.

Add a Comment

==[Click 2x to Close X]==
Most Popular Today!

Sorry. No data so far.